Siva Therapeutics is developing a cancer treatment which promises to be minimally invasive, to reduce harmful side effects, and to stimulate the immune system. In addition to being more affordable, this technology could deliver faster results than current cancer treatments. Siva achieves this treatment, termed Targeted Hyperthemia™, using SivaRod™ gold nanorods and a SivaLum™ infrared light device, which generates therapeutic heat emanating from within solid tumors.
Vision: To develop new cancer therapies that will save lives and not be dreaded by patients.
Mission: To develop a minimally-invasive, practical, safe, cost-effective, and efficacious device therapy for cancer using proprietary nanotechnology. To bring to market a product that will improve the efficacy of current cancer treatments and provide another tool for oncologists. To build a company that will gain and maintain a leadership position in the market for device therapies in cancer treatment.